TC Biopharm (Holdings) Plc (TCBP)

TC Biopharm (Holdings) Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.46	4.81	1.57	0.75	0.96
Cash & Cash Equivalents	2.46	4.81	1.57	0.75	0.96
Cash Growth	-48.78%	206.89%	109.45%	-21.80%	-
Receivables	0	0	0.88	0.29	1.31
Other Current Assets	3.24	2.64	1.41	1.18	1.95
Total Current Assets	5.7	7.45	3.86	2.22	4.22
Property, Plant & Equipment	2.62	3.29	3.68	4.63	5.61
Goodwill and Intangibles	0.62	0.55	0.48	0.42	0.31
Total Long-Term Assets	3.23	3.84	4.17	5.05	5.92
Total Assets	8.93	11.29	8.02	7.27	10.14
Accounts Payable	4.43	2.16	4.1	1.77	1.44
Deferred Revenue	0	0	3.84	5.82	7.8
Current Debt	0.31	0.98	14.5	0.44	0.41
Other Current Liabilities	0.01	6.02	-1.87	-3.84	-5.77
Total Current Liabilities	4.75	9.16	20.58	4.19	3.88
Long-Term Debt	1.5	1.8	2.14	2.58	3.02
Other Long-Term Liabilities	0	0	1.87	3.84	5.77
Total Long-Term Liabilities	1.5	1.8	4	6.43	8.79
Total Liabilities	6.25	10.96	24.58	10.61	12.68
Total Debt	1.8	2.78	16.63	3.03	3.44
Debt Growth	-35.17%	-83.30%	449.88%	-12.02%	-
Retained Earnings	-38.84	-33.37	-33.47	-19.89	-15.42
Shareholders' Equity	2.69	0.33	-16.56	-3.35	-2.54
Net Cash / Debt	0.66	2.03	-15.07	-2.28	-2.48
Net Cash / Debt Growth	-67.41%	-	-	-	-
Net Cash Per Share	0.11	2.95	-	-	-
Working Capital	0.95	-1.72	-16.72	-1.97	0.34
Book Value Per Share	8.69	9.64	-597.68	-120.81	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).